Results 61 to 70 of about 390,088 (309)
Ophthalmology (Rochester, Minn.)PURPOSE To evaluate the 2-year efficacy, durability, and safety of the bispecific antibody, faricimab, which inhibits both angiopoietin-2 and vascular endothelial growth factor-A.
Arshad M. Khanani +19 more
semanticscholar +1 more source
A simulation tool for better management of retinal services
BMC Health Services Research, 2018 Background Advances in the management of retinal diseases have been fast-paced as new treatments become available, resulting in increasing numbers of patients receiving treatment in hospital retinal services. These patients require frequent and long-term
Eren Demir +3 more
doaj +1 more source
One-Year Results of Using a Treat-and-Extend Regimen without a Loading Phase with Anti-VEGF Agents in Patients with Treatment-Naive Diabetic Macular Edema [PDF]
, 2019 PURPOSE: To evaluate real-life outcomes in treatment-naive patients with diabetic macular edema (DME) treated with anti-vascular endothelial growth factor (VEGF) agents using a treat-and-extend regimen without a fixed loading phase.
Zinkernagel, Martin S. +4 more
core +1 more source
Long-term results of anti-VEGF therapy in macular edema caused by central retinal vein occlusion
Российский офтальмологический журнал, 2023 Purpose. To evaluate long-term results of anti-VEGF therapy performed in a modified “treat-and-extend” regimen in macular edema secondary to central retinal vein occlusion.Material and methods.
A. B. Galimova, V. U. Galimova
doaj +1 more source
, 2017 PURPOSE To compare the enlargement rate of macular atrophy (ERMA) in eyes treated with ranibizumab monthly or using a treat-and-extend (TREX) regimen for neovascular age-related macular degeneration (AMD) or fellow control eyes, as well as analyze risk ...
Sadda, SriniVas R +6 more
core +1 more source
Frontiers in Medicine, 2022 PurposeTo compare the efficacy and safety of conbercept using a treat-and-extend (T&E) regimen vs. a pro re nata (PRN) regimen in Chinese patients with neovascular age-related macular degeneration (nAMD).MethodsThis was a randomized, multicenter, non-
Huixun Jia +22 more
doaj +1 more source
Survival of patients treated with extended-hours haemodialysis in Europe: an analysis of the ERA-EDTA Registry [PDF]
Nephrology Dialysis Transplantation, 2019 Abstract Background Previous US studies have indicated that haemodialysis with ≥6-h sessions [extended-hours haemodialysis (EHD)] may improve patient survival. However, patient characteristics and treatment practices vary between the USA and Europe.
Jansz, Thijs Thomas +15 more
openaire +8 more sources
BMC Ophthalmology, 2021 Purpose To describe real-life data from wet age-related macular degeneration (AMD) patients treated with anti-vascular endothelial growth factors (VEGFs) and to compare our results with previous studies and clinical trials.
Paolo Corazza +6 more
doaj +1 more source
Treat & extend versus PRN in AMD
Acta Ophthalmologica, 2016 SummaryBasically 3 different approaches to anti‐VEGF treatment in AMD are in clinical use, a fixed regimen using monthly or bi‐monthly injections (IVI), a PRN strategy and a Treat and Extend (T&E) regimen.T&E is a proactive and individualized anti‐VEGF treatment regimen. Basically IVI are performed monthly until stability is achieved.
openaire +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen +23 more
wiley +1 more source